Cargando…
Correction: A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528292/ https://www.ncbi.nlm.nih.gov/pubmed/34669740 http://dx.doi.org/10.1371/journal.pone.0259072 |
| _version_ | 1784586221453836288 |
|---|---|
| author | Kim, Ji Bak Song, Woo Hyuk Park, Jong Sung Youn, Tae-Jin Park, Yong Hyun Kim, Shin-Jae Ahn, Sung Gyun Doh, Joon-Hyung Cho, Yun-Hyeong Kim, Jin Won |
| author_facet | Kim, Ji Bak Song, Woo Hyuk Park, Jong Sung Youn, Tae-Jin Park, Yong Hyun Kim, Shin-Jae Ahn, Sung Gyun Doh, Joon-Hyung Cho, Yun-Hyeong Kim, Jin Won |
| author_sort | Kim, Ji Bak |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8528292 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Public Library of Science |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85282922021-10-21 Correction: A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia Kim, Ji Bak Song, Woo Hyuk Park, Jong Sung Youn, Tae-Jin Park, Yong Hyun Kim, Shin-Jae Ahn, Sung Gyun Doh, Joon-Hyung Cho, Yun-Hyeong Kim, Jin Won PLoS One Correction Public Library of Science 2021-10-20 /pmc/articles/PMC8528292/ /pubmed/34669740 http://dx.doi.org/10.1371/journal.pone.0259072 Text en © 2021 Kim et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Correction Kim, Ji Bak Song, Woo Hyuk Park, Jong Sung Youn, Tae-Jin Park, Yong Hyun Kim, Shin-Jae Ahn, Sung Gyun Doh, Joon-Hyung Cho, Yun-Hyeong Kim, Jin Won Correction: A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia |
| title | Correction: A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia |
| title_full | Correction: A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia |
| title_fullStr | Correction: A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia |
| title_full_unstemmed | Correction: A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia |
| title_short | Correction: A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia |
| title_sort | correction: a randomized, open-label, parallel, multi-center phase iv study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk asian patients with hypercholesterolemia |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528292/ https://www.ncbi.nlm.nih.gov/pubmed/34669740 http://dx.doi.org/10.1371/journal.pone.0259072 |
| work_keys_str_mv | AT kimjibak correctionarandomizedopenlabelparallelmulticenterphaseivstudytocomparetheefficacyandsafetyofatorvastatin10and20mginhighriskasianpatientswithhypercholesterolemia AT songwoohyuk correctionarandomizedopenlabelparallelmulticenterphaseivstudytocomparetheefficacyandsafetyofatorvastatin10and20mginhighriskasianpatientswithhypercholesterolemia AT parkjongsung correctionarandomizedopenlabelparallelmulticenterphaseivstudytocomparetheefficacyandsafetyofatorvastatin10and20mginhighriskasianpatientswithhypercholesterolemia AT yountaejin correctionarandomizedopenlabelparallelmulticenterphaseivstudytocomparetheefficacyandsafetyofatorvastatin10and20mginhighriskasianpatientswithhypercholesterolemia AT parkyonghyun correctionarandomizedopenlabelparallelmulticenterphaseivstudytocomparetheefficacyandsafetyofatorvastatin10and20mginhighriskasianpatientswithhypercholesterolemia AT kimshinjae correctionarandomizedopenlabelparallelmulticenterphaseivstudytocomparetheefficacyandsafetyofatorvastatin10and20mginhighriskasianpatientswithhypercholesterolemia AT ahnsunggyun correctionarandomizedopenlabelparallelmulticenterphaseivstudytocomparetheefficacyandsafetyofatorvastatin10and20mginhighriskasianpatientswithhypercholesterolemia AT dohjoonhyung correctionarandomizedopenlabelparallelmulticenterphaseivstudytocomparetheefficacyandsafetyofatorvastatin10and20mginhighriskasianpatientswithhypercholesterolemia AT choyunhyeong correctionarandomizedopenlabelparallelmulticenterphaseivstudytocomparetheefficacyandsafetyofatorvastatin10and20mginhighriskasianpatientswithhypercholesterolemia AT kimjinwon correctionarandomizedopenlabelparallelmulticenterphaseivstudytocomparetheefficacyandsafetyofatorvastatin10and20mginhighriskasianpatientswithhypercholesterolemia |